“…Recent studies have shown the utility of contrastenhanced MRC especially in visualizing non-dilatated bile ducts (e.g., in living liver donors) and biliary leaks [4,5,11]. Currently, three different hepatobiliary contrast agents are available for contrast-enhanced MRC: mangafodipir trisodium (Mn-DPDP; Teslascan; GE Healthcare, Oslo, Norway), gadobenate dimeglumine (Gd-BOPTA; MultiHance, Bracco Imaging, Milan, Italy), and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA, gadoxetic acid; Primovist, Bayer Schering Pharma, Berlin, Germany).…”